Exact Sciences
EXAS
EXAS was delisted on the 20th of March, 2026.
480 hedge funds and large institutions have $5.26B invested in Exact Sciences in 2022 Q3 according to their latest regulatory filings, with 60 funds opening new positions, 179 increasing their positions, 133 reducing their positions, and 77 closing their positions.
35% more repeat investments, than reductions
Existing positions increased: 179 | Existing positions reduced: 133
10% more call options, than puts
Call options by funds: $72.4M | Put options by funds: $65.6M
1.01% less ownership
Funds ownership: 92.41% → 91.4% (-1%)
4% less funds holding
Funds holding: 501 → 480 (-21)
20% less capital invested
Capital invested by funds: $6.54B → $5.26B (-$1.28B)
22% less first-time investments, than exits
New positions opened: 60 | Existing positions closed: 77
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
+$107M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
+$100M |
| 3 |
AC
Armistice Capital
New York
|
+$64.3M |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
+$47.2M |
| 5 |
Sumitomo Mitsui Trust Group
Minato-Ku, Tokyo,
Japan
|
+$29.3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$396M |
| 2 |
EC
Eminence Capital
New York
|
-$97.3M |
| 3 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
-$76.3M |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$50.3M |
| 5 |
Capital World Investors
Los Angeles,
California
|
-$37.1M |
EXAS Hedge Fund Activity: Q3 2022 in Review
480 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in Exact Sciences (EXAS) for Q3 2022, worth a combined $5.26B — down 20% from $6.54B a quarter earlier.
Sellers outnumbered buyers: 77 funds closed out of EXAS and 60 opened new positions — a net loss of 17 holders — while 133 trimmed existing stakes and 179 added.
The largest buyer was ARK Investment Management, adding an estimated $107M. The largest seller was T. Rowe Price Associates, cutting an estimated $396M.
- 480 institutional investors held Exact Sciences (EXAS) as of Q3 2022, down from 501 in Q2 2022.
- Funds reported $5.26B of Exact Sciences stock for Q3 2022, down 20% quarter-over-quarter.
- 60 funds opened new Exact Sciences positions in Q3 2022 and 77 closed out, a net change of -17 holders.
- The largest Exact Sciences buyer in Q3 2022 was ARK Investment Management, an estimated $107M added.
- The largest Exact Sciences seller in Q3 2022 was T. Rowe Price Associates, an estimated $396M sold.
Based on aggregated 13F filings for Q3 2022.